Skip to main content

Neuraci Labs

Neuraci Labs is building the Human Smell Graph, a programmable layer for olfactory biology that aims to map and decode the sense of smell. The company offers tools for researchers and organizations to explore how odor molecules translate into neural signals and biological responses linked to health and behavior. Its technology could enable early disease detection and sensory intelligence applications previously out of reach.

New York City, United States · HQ
Founded 2025111K+ followers
  • Artificial Intelligence
  • Biotechnology
  • Digital Health
  • Drug Discovery & Therapeutics
  • Healthcare Technology
  • Software Only
Updated yesterday

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

The sense of smell has long been considered unorganized and difficult to study, lacking the structured maps that exist for vision or hearing. This gap limits scientific understanding of how odors influence the brain and body, and hampers the development of diagnostic or therapeutic applications based on olfactory signals.

Solution

Neuraci Labs is creating the Human Smell Graph, an emerging platform that systematically maps the relationship between chemical compounds and their biological effects. The company aims to make smell "programmable" by providing researchers with tools to explore, annotate, and query olfactory pathways in a structured, data-driven way. By integrating molecular, neural, and behavioral data, Neuraci Labs enables the discovery of patterns that link smell to memory, emotion, and early signs of neurological disease.

Target Audience

Primary audience includes academic researchers in olfaction and sensory neuroscience, as well as clinical partners investigating olfactory markers for neurodegenerative disease and therapeutic applications.

Features

  • Development of a structured "smell graph" that links odor molecules to neural transduction and downstream physiological outcomes
  • Tools for exploring the olfactory pathway from airborne molecule to cognitive response, including memory and emotional states
  • Focus on clinical applications such as early screening for Parkinson's and Alzheimer's through olfactory biomarkers
  • Platform architecture designed for integration with research workflows in sensory neuroscience and diagnostic development
  • Infrastructure positioned for future partnerships with health systems and sensory intelligence companies
This profile is AI-generated and may contain inaccuracies.